Published 3 days ago • loading... • Updated 3 days ago
Texas Woman Goes to a Hospital for Help with Pain Related to Sickle Cell Anemia, only to Be Told ‘Seems Like You’re Trying to Get High’
Summary by We Got This Covered
4 Articles
4 Articles
FDA Approves First Gene Therapy for Young Children with Sickle Cell Disease
The U.S. Food and Drug Administration today issued a supplemental approval for Casgevy (exagamglogene autotemcel) for patients aged 2 years and older with either sickle cell disease (SCD) with recurrent vaso-occlusive crises (VOCs) or transfusion-dependent β thalassemia (TDT).
Reposted by
Business News This Week
Children’s Hospital Los Angeles Studies New Gene-Editing Approach for Sickle Cell Disease
Children’s Hospital Los Angeles is participating in RESTORE, an early-stage clinical trial studying an investigational CRISPR-Cas9 therapy designed to directly modify the beta-globin gene in sickle cell disease.
Coverage Details
Total News Sources4
Leaning Left1Leaning Right1Center0Last Updated50% Left, 50% Right
Bias Distribution
- 50% of the sources lean Left, 50% of the sources lean Right
50% Right
L 50%
R 50%
Factuality
To view factuality data please Upgrade to Premium


